▶ Dierks E.A. et al., A method for the simultaneous evaluation of theactivities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. Drug Metab. Dispos. 2001; 29: 23-29.
▶ Unger M, Frank A, Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun. Mass Spectrom. 2004; 18: 2273-2281.
▶ Walsky R.L., Obach R.S., Validated assays for human cytochrome P450 activities. Drug Metab. Dispos. 2004; 32: 647-660.
▶ Crespi C.L. et al., Microtiter plate assays for inhibition of human drug-metabolizing cytochromes P450. Anal. Biochem. 1997; 248: 188-190.
▶ Chauret N. et al., Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe. Anal. Biochem. 1999; 276: 215-226.
▶ Yueh M.F. et al., High volume bioassays to assess CYP3A4-mediated drug interactions: induction and inhibition in a single cell line. Drug Metab. Dispos. 2005; 33: 38-48.
▶ Draper A.J. et al., Development of a non-high pressure liquid chromatography assay to determine testosterone hydroxylase (CYP3A) activity in human liver microsomes. Drug Metab. Dispos. 1998; 26: 299-304.
▶ Di Marco A. et al., Development and validation of a high-throughput radiometric CYP3A4/5 inhibition assay using tritiated testosterone. Drug Metab. Dispos. 2005; 33: 349-358.
▶ Zou L. et al., Effects of intrinsic fluorescence and quenching on fluorescence-based screening of natural products. Phytomedicine 2002; 9: 263-267.